Many people think of influenza as a harmless illness, but it can lead to serious complications and can affect anyone
  • HIV/AIDS – Causes, Signs, Symptoms & Prevention

    Acquired Immunodeficiency Syndrome (AIDS) refers to a range of symptoms which are caused due to Human Immunodeficiency Virus (HIC) infection. After the infection occurs, the person usually does not experience very pronounced symptoms but may go through influenza-like symptoms. Following this, there is a long period that is typically...
  • Kite’s Yescarta™

    Kite, a Gilead Company, (Nasdaq: GILD)  announced that the U.S. Food and Drug Administration (FDA) has granted regular approval to Yescarta™ (axicabtagene ciloleucel), the first chimeric antigen receptor T cell (CAR T) therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or...
  • A PATIENT GETS THE NEW TRANSGENDER SURGERY SHE HELPED INVENT

    LIKE MANY OTHER surgery patients, Hayley Anthony has a daily physical therapy regimen. But unlike other post-ops, the 30-year-old marketing consultant is recovering from a procedure she helped invent. Five months ago, she became one of the first people in the world to have a piece of tissue incised from...
  • ANTIBIOTIC-BRINED CHICKEN AND OTHER BAD IDEAS FROM US FARMING

    THESE DAYS, THE only thing more American than apple pie is eating an animal raised on antibiotics. Eighty percent of antibiotics sold in the US go not to human patients, but to the nation’s plate-bound pigs, cows, turkeys, and chickens. As these wonder drugs became a mainstay of modern agriculture, factory farms...
  • FDA OKs Tisagenlecleucel in ALL as First Approved CAR T-Cell Therapy

    The FDA issued a historic approval of the first chimeric antigen receptor (CAR) T-cell Therapy, authorizing the use of tisagenlecleucel (Kymriah) for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. The...
  • Emmaus bags FDA approval for sickle cell therapy; now comes the hard part

    An FDA greenlight for sickle cell disease therapy Endari has catapulted its developer, Emmaus Medical, into the spotlight, but commercializing the new drug could be challenging. The approval means the privately-held biotech has ended a 20-year drought in new therapies for sickle cell disease (SCD), an inherited disease in which red...
  • Human Papillomavirus (HPV) Vaccines

    ON THIS PAGE      What are human papillomaviruses? Which cancers are caused by HPV? Who gets HPV infections? Can HPV infections be prevented? What HPV vaccines are available? Who should get the HPV vaccines? How do HPV vaccines work? How effective are HPV vaccines? Why are these vaccines...
  • 17 Concise Reasons Why Homeopathy is a Fraud

    One can’t help but be perplexed by the bizarre world of #homeopathy . From miracle cures to snake oil peddling, from deceptive advertising to FDA warnings, from questionable medical claims to rigorous scientific testing, it’s an uncanny circle of health declarations and assertions. Here is hopefully a comprehensive overview...
  • HEALTH APR 6 2017, 10:43 AM ET Cancer-Causing HPV Virus Affects 25 Percent of U.S. Men: Study

    A quarter of men and 20 percent of women have the strain of HPV (human papillomavirus or human wart virus) that causes cancer, new government statistics show. And 45 percent of men have some kind of genital #HPV , the latest data from the National Center for Health Statistics...

Popular Posts

  • Morem ipsum dolor sit amet, consectetur adipiscing elit. Cras faucibus lorem et lectus sollicitudin sollicitudin. Nulla facilisi. Cras vestibulum rutrum lorem nec placerat. Fusce facilisis nisl nisl, eu fringilla...
  • Morem ipsum dolor sit amet, consectetur adipiscing elit. Cras faucibus lorem et lectus sollicitudin sollicitudin. Nulla facilisi. Cras vestibulum rutrum lorem nec placerat. Fusce facilisis nisl nisl, eu fringilla...
  • Morem ipsum dolor sit amet, consectetur adipiscing elit. Cras faucibus lorem et lectus sollicitudin sollicitudin. Nulla facilisi. Cras vestibulum rutrum lorem nec placerat. Fusce facilisis nisl nisl, eu fringilla...
  • Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras faucibus lorem et lectus sollicitudin sollicitudin. Nulla facilisi. Cras vestibulum rutrum lorem nec placerat. Fusce facilisis nisl nisl, eu fringilla...
Close